Bachem Holding Competitors and Similar CompaniesClear all
Bachem Holding's competitors and similar companies include Catalent, PPD, Catalent Pharma Solutions and Hetero.
 Bachem Holding Bachem Holding is a company that manufactures ingredients for pharmaceuticals, generic drugs, and research supplies. |  Catalent Catalent is a company that develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, vaccines, and consumer health products. |  PPD PPD (Pharmaceutical Product Development) is a company that provides drug development and laboratory solutions. |  Catalent Pharma Solutions Catalent Pharma Solutions is a company that provides drug delivery technologies and manufactures solutions for drugs, protein, cell, and gene therapy biologics, and consumer health products. |  Hetero Hetero is a generic pharmaceutical company engaged in the development, manufacturing, and marketing of chemical and biologic drugs. | |
Founding Date | Founding Date 1971 | Founding Date 2007 | Founding Date 1985 | Founding Date 1989 | Founding Date 1993 |
Type | Type Public | Type Subsidiary | Type Subsidiary | Type Subsidiary | Type Private |
Tags | |||||
Locations | Locations Bubendorf, CH HQ Tokyo, JP Torrance, US | Locations Bridgewater, US HQ Buenos Aires, AR Bruxelles, BE Charleroi, BE Charleroi, BE Charleroi, BE Indaiatuba, BR see more | Locations Wilmington, US HQ Buenos Aires, AR Melbourne, AU Brussels, BE Zaventem, BE São Paulo, BR São Paulo, BR see more | Locations Somerset, US HQ | Locations Hyderabad, IN HQ Norwest, AU Sao Paulo, BR Beijing, CN Nanjing Shi, CN Nanjing Shi, CN Bogotá, CO see more |
Employees | Employees 2,207 | Employees 12,6955% increase | Employees 24,5842% decrease | Employees 8,300 | Employees 7,0042% increase |
Financial | |||||
Revenue (est.) | Revenue (est.) CHF695.1m (FY, 2025) | Revenue (est.) $4.4b (FY, 2024) | Revenue (est.) $4.7b (FY, 2020) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods CHF447.9m (FY, 2025) | Cost of goods $3.4b (FY, 2024) | Cost of goods $1.7b (FY, 2020) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit CHF264.2m (FY, 2025) | Gross profit $953m (FY, 2024) | Gross profit $3b (FY, 2020) | Gross profit N/A | Gross profit N/A |
Net income | Net income CHF148.8m (FY, 2025) | Net income ($1b) (FY, 2024) | Net income $160.6m (FY, 2020) | Net income N/A | Net income N/A |
Operating ⚠ | |||||
Backlog | Backlog N/A | Backlog $2.5b (FY, 2023) | Backlog $9.5b (Q3, 2021) | Backlog N/A | Backlog N/A |
Countries | Countries N/A | Countries 80 (FY, 2023) | Countries 46 (FY, 2020) | Countries N/A | Countries 126 (Jan, 2021) |
Products | Products N/A | Products 8 k (FY, 2023) | Products N/A | Products N/A | Products 200 (Jan, 2021) |
For sources of this data, please see the company profile
View Company Profiles
Catalent
HQ
Bridgewater, US
Catalent is a company that develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, vaccines, and consumer health products.
View companyPPD
HQ
Wilmington, US
PPD (Pharmaceutical Product Development) is a company that provides drug development and laboratory solutions.
View companyCatalent Pharma Solutions
HQ
Somerset, US
Catalent Pharma Solutions is a company that provides drug delivery technologies and manufactures solutions for drugs, protein, cell, and gene therapy biologics, and consumer health products.
View companyHetero
HQ
Hyderabad, IN
Employees
7,004↑ 2% increase
Hetero is a generic pharmaceutical company engaged in the development, manufacturing, and marketing of chemical and biologic drugs.
View company